MMP16 and bladder transitional cell carcinoma: Lastly, another member of the miR200 family, miR200b, was demonstrated to target matrix metalloproteinase-16 (MMP16) in BlCa cell lines, which is downregulated by transforming growth factor beta 1 (TGF-β1), previously associated with metastatic potential acquisition.